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Abstract
Background: To determine if the search technique that is used to sample randomized controlled
trial (RCT) manuscripts from a field of medical science can influence the measurement of the
change in quality over time in that field.
Methods: RCT manuscripts in the field of brain injury were identified using two readily-available
search techniques: (1) a PubMed MEDLINE search, and (2) the Cochrane Injuries Group (CIG)
trials registry. Seven criteria of quality were assessed in each manuscript and related to the year-
of-publication of the RCT manuscripts by regression analysis.
Results: No change in the frequency of reporting of any individual quality criterion was found in
the sample of RCT manuscripts identified by the PubMed MEDLINE search. In the RCT manuscripts
of the CIG trials registry, three of the seven criteria showed significant or near-significant increases
over time.
Conclusions: We demonstrated that measuring the change in quality over time of a sample of
RCT manuscripts from the field of brain injury can be greatly affected by the search technique. This
poorly recognized factor may make measurements of the change in RCT quality over time within
a given field of medical science unreliable.
Background
Considerable effort has been directed toward improving
randomized controlled trial (RCT) design, execution, and
reporting [1-6,14]. Such efforts to define standards of
quality for RCTs beg the question: are RCTs improving in
quality over time? Many reviews have attempted to
answer this question. In general, these reviews measure
the presence or absence of several criteria chosen to define
quality in a sample of RCT manuscripts that was selected
from a parent population of RCT manuscripts. The parent
population of RCT manuscripts may be either a field of
medical science or a defined part of the medical literature
(e.g., RCT manuscripts from a chosen journal). Then, by
examining a score of quality as a function of the year-of-
publication of the sampled RCT manuscripts, conclusions
are drawn as to whether or not quality is changing over
time in the parent population of RCTs. If such reviews are
to be useful, then, the sample of RCT manuscripts that was
chosen for analysis must represent the parent population
of RCT manuscripts.
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As much as the RCT manuscripts published in a single
journal or group of journals would provide a well-defined
parent population, the RCT manuscripts from a given
field of medical science would be difficult to completely
identify. Ultimately no search strategy can claim to iden-
tify all manuscripts on a given topic that have been pub-
lished in every book and journal worldwide. Thus, two
search techniques might provide considerably different
samples of RCT manuscripts from the same field of med-
ical science depending upon how much and / or what
parts of the parent population of RCT manuscripts they
can access. The current communication empirically dem-
onstrates this point as a potential pitfall in measuring the
change in quality over time of RCT manuscripts sampled
from a representative field of medical science.
Methods
Criteria of quality
We chose internal validity as a measure of quality accord-
ing to the definition given by Gehlbach [7], namely that a
RCT is internally valid when "within the confines of the
study, results appear to be accurate and interpretation of
the investigators is supported". We selected criteria of
internal validity according to the recommendations of
Moher et al. [8]. The relevant points are addressed below.
I. Definition of the quality construct
We intended to measure the presence or absence of vari-
ous criteria of RCT quality as described in the published
manuscript. No attempt was made to contact the authors
of a manuscript either to clarify the information provided
in the manuscript or to gain additional information about
a RCT. We acknowledge that relying on the published
manuscript in order to assess the quality of a RCT may be
biased (1) against well-designed RCTs that were reported
in poorly written manuscripts and (2) in favor of poorly-
designed RCTs that were reported in well-written manu-
scripts [9]. Thus, our scoring process ultimately measured
the quality of the report of the RCT manuscript, rather
than the true methodological quality of the trial as it was
conducted. However, attempting to obtain an under-
standing of the true methodological quality of a RCT in a
retrospective manner by contacting the authors of the
manuscripts would undoubtedly collect more informa-
tion on recent RCTs because their authors will be more
accessible (i.e., less likely to have relocated, retired, or
died). Attempting to contact the authors of manuscripts is
rarely successful [10] and, when it is successful, accurate
information about the design and conduct of the RCT is
not always forthcoming [11,12].
II. Definition of the scope of internal validity and identification of 
quality criteria
Although random allocation and the use of a concurrent
control group are the sine qua non of the RCT, additional
criteria have been so frequently included in their design
and execution that they are now commonly considered as
part of quality RCTs. Several sources (themselves located
by PubMed MEDLINE and bibliography searches) were
used to identify such criteria [2,9,13-18]. After forming a
composite list of internal validity criteria from these
sources, we searched the literature (again by means of
PubMed MEDLINE and bibliographies) for instances
where the presence or absence of each criterion in a RCT
affected the results obtained from the RCT. Thus, we iden-
tified criteria that were supported by empirical evidence as
measures of RCT quality. We identified six criteria that
had predominantly supporting evidence in their favor.
Subsequently, allocation concealment was included as a
separate quality criteria. The quality criteria, with brief
descriptions, are listed in Table 1.
We limited our quality scale to measure criteria that have
been demonstrated empirically to be associated with the
quality of RCTs. This necessarily excluded many items
associated with RCT design and execution that are widely
thought to affect quality or that are included in com-
monly-used quality scales, but it provided us with a defen-
sible "bare minimum" definition of quality. It should be
noted that we did not intend our list of criteria to be
encompassing of all aspects of quality; our criteria were
intended to serve only as a tool for the comparative anal-
ysis of the two sets of RCT manuscripts for the purpose of
this study.
III. Scoring System
Each of the seven criteria was scored as being present (1
point) or as absent (0 points) in the RCT manuscript. Def-
initions of each criterion are shown in Table 1. If a RCT
manuscript did not mention the presence of a criterion, it
was considered absent. Conversely, all written statements
in the manuscripts were assumed to be accurate both fac-
tually and semantically.
IV. Criteria Scoring Verification
The intra-rater reliability for the scoring of the quality cri-
teria was determined by comparing the individual criteria
scores given to n = 16 RCT manuscripts by one of the
authors of this communication (MKB) on two occasions
separated by 3 weeks. The correlation coefficient (Kappa)
measured in this manner was 0.94.
Inter-rater reliability was determined by comparing the
quality criteria scores given to n = 10 RCT manuscripts by
two different examiners. One copy of each manuscript
was scored by one of the authors of this communication
(MKB) while the other copy was scored by an independ-
ent examiner (Dr. Babak Jahromi, Department of Neuro-
surgery, the University of Toronto) who was provided
with a thorough description of the criteria. The correlationBMC Medical Research Methodology 2005, 5:7 http://www.biomedcentral.com/1471-2288/5/7
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coefficient (Kappa) for inter-rater reliability was deter-
mined to be 0.74.
Manuscript selection and the screening process
We chose to evaluate the field of brain injury because two
search techniques for sampling the population of these
RCT manuscripts were readily available. The first search
technique was our own PubMed MEDLINE search. The
second search technique was performed by the Cochrane
Collaboration Injuries (CIG) Group, and forms the CIG
trials registry. Copies of the RCT manuscripts identified by
these two search techniques were retrieved through the
library holdings and interlibrary loan services of five
universities.
Next, the manuscripts were read by one of us (CY) to
screen-out inappropriately identified manuscripts. Table
2 provides a detailed list of these exclusions. Inherent in
the phrase 'randomized controlled trial' is (1) the random
allocation of patients into multiple groups for prospective
analysis, and (2) the concurrent comparison of at least
one group that receives the experimental treatment
against another group that does not; manuscripts that did
not include random allocation and a concurrent control
group were excluded. Furthermore, in order for a manu-
script to be considered pertinent to the study of brain
injury one of the following conditions had to be met: (1)
brain injury had to directly define the patient population;
(2) brain injury had to be the cause of a second condition
(e.g., seizures) that defined the patient population; or (3)
brain injury had to be the outcome measure for the
patient population. If none of the above conditions were
met the manuscript was discarded from further examina-
tion. Duplicate publications, protocol descriptions,
abstracts, letters-to-the-editor, and incomplete or prelimi-
nary reports were also removed during the screening
process.
The design and yield of the two search techniques was as
follows:
1) the PubMed MEDLINE search: The first search technique
we used to identify RCT manuscripts pertaining to brain
injury involved the PubMed search engine of the
MEDLINE database. It was designed to represent a typical
literature search performed by a North American
researcher who is fluent only in English. The search term
"brain injuries" (C10.228.140.199) was used with the
Table 1: The quality scale This table lists the criteria of quality that were used to score the RCT manuscripts. Abbreviated definitions 
for the presence (1 point) or absence (0 points) of each criterion are provided.
1) assessment of the distribution of patient characteristics and prognostic factors between groups
present distribution of patient characteristics and prognostic factors assessed without asymmetry between groups
absent not mentioned; distribution of patient characteristics and prognostic factors assessed with asymmetry noted between 
groups
2) prevention of the movement of patients between groups after allocation, and the use of intention-to-treat analysis
present use of intention-to-treat analysis; no movement of patients between groups confirmed
absent not mentioned; patients known to change groups before analysis
3) the blinding of the patients to the treatment they received
present statements of double-blind present; use of a placebo; statements of the treatments being indistinguishable present; patients 
not aware of study due to clinical condition
absent not mentioned; lack of placebo use in control group; readily-distinguishable treatments; blinding breakdown confirmed
4) the blinding of the health care providers to the treatments received by the patients
present third-party dispensation of treatments; statements of health care provider blinding present; health care provider identical 
to outcome observer, and outcome observer is blinded
absent not mentioned; health care team aware of patient allocation; lack of placebo in control condition; readily-distinguishable 
treatments; blinding breakdown confirmed
5) the blinding of the outcome observer to the treatment received by the patient
present statements of double blind present; objective outcome; use of standardized tests or questionnaires that do not require an 
outcome observer; subjective principle outcome but outcome observer blinded to treatment; blinded health care providers 
performing outcome assessment
absent not mentioned; subjective outcome without blinding of the outcome observer; blinding breakdown confirmed
6) completeness of follow-up
present no patients lost to follow-up; acute experimental design does not permit loss of patients; analysis of lost patients provided 
according to randomization groups, with reason for loss
absent not mentioned; no analysis of lost patients provided; effect of patient loss to follow-up confirmed
7) allocation concealment
present use of consecutive opaque envelopes or pre-ordered treatments; third party assignment of allocation
absent not mentioned; repeatable pattern of allocation; use of obvious identifiers for allocation (e.g., birth date, record number); 
assignment of treatment by treating physicianBMC Medical Research Methodology 2005, 5:7 http://www.biomedcentral.com/1471-2288/5/7
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limitations of (1) randomized controlled trial, (2) human
subjects, and (3) publication in English. The PubMed
MEDLINE search included manuscripts indexed from Jan-
uary, 1966, up to February, 2001 (the time at which the
search was performed).
The PubMed MEDLINE search identified n = 139
manuscripts. During the screening process, n = 41
manuscripts from the original 139 (30%) were dis-
carded leaving n = 98 manuscripts (see Table 2 for  a
detailed list of the exclusions).
2.) the CIG trials registry: The Injuries Group of the
Cochrane Collaboration was kind enough to share their
list of RCT manuscripts with us for the purpose of con-
ducting this study. The list of manuscripts they provided
was compiled by means of the following three steps:
step 1) The CIG trials master list was searched
using the keywords "head" or "brain" in conjunction
with "injur*" or "trauma*". The CIG trials
master list is a local database maintained at the London
School of Hygiene and Tropical Medicine that
uses a detailed search strategy to identify RCTs
from multiple computerized databases (a copy
of this search strategy is available from Ms. Fiona
Renton of the London School of Hygiene and
Tropical Medicine Fiona.Renton@lshtm.ac.uk) as
well as various hand searches of journals per-
formed during the writing of systemic reviews; it is
updated quarterly.
step 2) MEDLINE, EMBASE, and CENTRAL
databases were searched using the exploded
keyword "head injuries:ME" or "head inju-
ries:TI". EMBASE includes references from 1974
onward and, while it uses its own database, it
is based on an indexing hierarchy which incorporates
that used by MEDLINE. Here, MEDLINE was
searched with the SilverPlatter search engine, not
with the PubMed Search engine. Manuscripts
of the MEDLINE database indexed as early as 1966
were accessible to the SilverPlatter search
engine. The CENTRAL database is a general list of
clinical trials that is maintained by the collab-
orative efforts of multiple Cochrane specialty groups.
step 3) Manuscripts identified by hand
searches of relevant journals and from references provided
by direct contact with experts in the field of
brain injury were also included.
The original CIG trials registry was completed in
1998 and was last fully updated in May, 2001; it is that
version which was used in our study.
The CIG trials registry included n = 312 manuscripts.
During the screening process, n = 139 manuscripts
from the original 312 (45%) were discarded leaving
n = 173 RCT manuscripts (see Table 2 for a  detailed
list of the exclusions).
3.) overlap between the PubMed MEDLINE search and the
CIG trials registry: Of the total unscreened samples of man-
uscripts identified through each search technique, n = 80
manuscripts were present in both samples; this corre-
sponded to 58% of the sample of manuscripts identified
by PubMed MEDLINE search and 26% of the sample of
manuscripts from the CIG trials registry. After the removal
of inappropriate manuscripts during the screening proc-
Table 2: Exclusion of manuscripts from the PubMed MEDLINE and CIG Trials Registry groups of manuscripts Manuscripts 
inappropriately identified by the PubMed MEDLINE search and the CIG trials registry were removed from review during a screening 
process performed by one of the authors of the current communication (CY).
reason for exclusion PubMed MEDLINE search CIG Trials Registry group
INITIALLY IDENTIFIED 139 312
libraries unable to locate 0 15
unrelated to brain injury 2 3
duplicate publications 2 8
inaccurately claimed to be a controlled trial 22 47
inaccurately claimed to use randomization 11 30
abstracts / letters-to-the-editor 1 31
protocol descriptions 3 0
incomplete / preliminary reports 0 4
non-human subjects 0 1
TOTAL NUMBER DISCARDED 41 139
REMAINING 98 (70% of initially identified) 173 (55% of initially identified)BMC Medical Research Methodology 2005, 5:7 http://www.biomedcentral.com/1471-2288/5/7
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ess, and scoring process only n = 56 manuscripts were
identified by both the PubMed MEDLINE search and the
CIG trials registry. This corresponded to 57% and 32% of
the PubMed MEDLINE search and the CIG trials registry
samples, respectively.
The scoring process
Each of the RCT manuscripts was read by both authors of
the current communication (CY and MKB) who, for clar-
ity's sake, will be referred to as "examiners". One examiner
("non-judging examiner": CY) performed the screening
process described previously, then recorded the year-of-
publication of each manuscript that survived the screen-
ing process in a computerized spreadsheet (Microsoft
Excel) and marked them with identification numbers.
Then, the non-judging examiner hid the names of the
authors of the manuscript, the authors' degrees and
departmental affiliations, the journal in which the RCT
manuscript was published, and the year-of-publication of
the manuscript with black marker. This information was
covered wherever it was found in the manuscript so that
when the manuscript was scored by the second examiner
("judging examiner": MKB) there would be no potential
for bias [8,19]. The data collected by the judging examiner
was entered into a computerized spreadsheet that was dif-
ferent from the one linking the year-of-publication of the
manuscripts with their identification numbers. The two
spreadsheets were combined only when all the manu-
scripts had been read.
As mentioned above, allocation concealment was
included in the list of quality criteria after the first evalua-
tion of the manuscripts. Accordingly, the judging exam-
iner re-read all the manuscripts specifically to determine
the inclusion of allocation concealment. The manuscripts
were still blinded as described above, and the data was
entered into a third spreadsheet that was subsequently
analyzed independently of the preexisting data.
Manuscripts in French and Spanish were read without
written translation by the judging examiner, whereas writ-
ten translations were provided to the judging examiner for
manuscripts in Japanese (by CY), German and Italian (by
Mrs. Margaret K. Borsody), and Chinese (by Language
Line, Inc., document translation service).
Statistical analysis
After completion of the scoring process, statistical analy-
ses were conducted by the judging examiner. The data was
considered interval in nature and thus data analysis for
discrete variables was used [20]. Furthermore, since this
study was constructed as a longitudinal analysis of the
change in quality scores over time, it was necessary to use
some form of regression analysis to examine the data.
Considering these requirements, binary logistic regression
analyses were performed for each individual quality crite-
ria. All statistical analyses were done by SPSS (version
11.5, SPSS Inc.). Scores for the individual quality criteria
were examined as dependent variables against the inde-
pendent variable of year-of-publication. Significance is
defined as a P < 0.05.
Since the samples of manuscripts from the PubMed
MEDLINE search and the CIG trials registry are known to
be derived from the same parent population of RCTs (i.e.,
RCTs in the field of brain injury), it is inappropriate to
directly compare them against each other with statistical
tests. Rather, it was our goal to analyze the two samples of
RCT manuscripts separately, and to make likely conclu-
sions about the parent population from each sample of
manuscripts as if there was no other sample of manu-
scripts available for comparison. Then, knowing that the
two samples of RCT manuscripts represent the same par-
ent population, it was our intention to compare the con-
clusions derived from the separate analyses to determine
the impact of the search technique thereupon.
Table 3: Regression analysis of individual quality criteria versus year-of-publication of the manuscripts identified by the PubMed 
MEDLINE search This table lists the results of the regression analyses comparing year-of-publication against the individual quality 
criteria.
quality criterion regression result
(W = Wald stat)
Cox & Snell R2 regression line
the assessment of the distribution of patient characteristics and prognostic 
factors between groups
W = 0.96, P = 0.33 0.01 y = -0.075x + 9.45
prevention of the movement of patients between groups after allocation, and 
the use of intention-to-treat analysis
W = 1.63, P = 0.20 0.02 y = 0.088x - 10.30
the blinding of the patients to the treatment they received W = 0.30, P = 0.58 0.003 y = 0.022x - 0.80
the blinding of the health care providers to the treatments received by the 
patients
W = 2.00, P = 0.16 0.02 y = 0.055x - 5.71
the blinding of the outcome observer to the treatment received by the patient W = 0.01, P = 0.93 0.000 y = 0.003x + 0.57
adequacy of follow-up W = 0.03, P = 0.86 0.000 y = -0.006x + 1.18
allocation concealment W = 1.06, P = 0.30 0.011 y = 0.39x - 78.4BMC Medical Research Methodology 2005, 5:7 http://www.biomedcentral.com/1471-2288/5/7
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Results
Regression analysis of the individual quality criteria
against the year-of-publication of the RCT manuscripts
was performed to determine if the frequency of reporting
of each quality criteria changed over time. For the sample
of RCT manuscripts identified by the PubMed MEDLINE
search, no significant relationship was found for any indi-
vidual quality criterion (listed in Table 3 with the results
from the statistical analysis). The RCT manuscripts identi-
fied by the CIG trials registry were also examined in this
manner. Analyzing each quality criterion individually as a
function of the year-of-publication of the manuscripts in
that sample showed that two criteria ("prevention of the
movement of patients between groups after allocation,
and the use of intention-to-treat analysis"; "the assess-
ment of the distribution of patient characteristics and
prognostic factors between groups") and nearly another
("completeness of follow-up") were reported in the man-
uscripts with increasing frequency over time (Table 4).
Discussion
Many of reviews have attempted to measure the change in
RCT quality over time in a field of medical science. It
occurred to us that such an analysis could be influenced
by the search technique that was used to identify the RCT
manuscripts. Based on this concern we hypothesized that
two samples of RCT manuscripts taken from the same
field of medical science by different search techniques
could provide different measures of the change in quality
over time. We empirically tested this hypothesis, and by
doing so demonstrated that the conclusions made about
the change in quality of RCT manuscripts from a repre-
sentative field of medical science could be significantly
influenced by the search technique that was used to sam-
ple the field. This demonstration may then bring into
question the validity of previous reviews that have
claimed to define the change in quality of RCTs over time
in various fields of medical science.
In our study, the samples of RCT manuscripts provided by
the PubMed MEDLINE search and the CIG trials registry
had less overlap than we would have expected considering
that both search techniques involved the MEDLINE data-
base. In particular, the CIG trials registry identified only
about 60% of the RCT manuscripts found by the PubMed
MEDLINE search despite involving its own search of the
MEDLINE database. This observation may ultimately
relate to the use of different search terms to identify man-
uscripts from the MEDLINE database, and to the use of
different search engines of the MEDLINE database (i.e.,
PubMed, versus SilverPlatter in the CIG trials registry) that
themselves can affect the identification of manuscripts
from the common database. Whatever may be the cause
for the discrepancy between our two samples, it may
undermine any claim that a search technique necessarily
produces a more representative sample from a field of
medical science simply because it identifies a greater
number of RCT manuscripts.
The two search techniques otherwise differ in several
ways. For example, the PubMed MEDLINE search was
designed so as to exclude any manuscripts published in a
non-English language. This would approximate the typi-
cal literature search performed by many researchers in
North America, and accordingly all the manuscripts iden-
tified by the PubMed MEDLINE search were readily avail-
able in local university libraries. Conversely, the CIG trials
registry tended to include more references from the non-
English language literature (n = 27 manuscripts after the
screening process). This inclusiveness of the CIG trials reg-
istry seemed to account for the 15 irretrievable manu-
scripts listed by the CIG trials registry. It is reasonable to
state that the non-English language literature is part of
Table 4: Regression analysis of individual quality criteria versus year-of-publication of the manuscripts identified by the CIG Trials 
Registry This table lists the results of the regression analyses comparing year-of-publication against the individual quality criteria.
quality criterion regression result
(W = Wald stat)
Cox & Snell R2 regression line
the assessment of the distribution of patient characteristics and prognostic 
factors between groups
W = 5.53, P = 0.02 0.03 y = 0.072x - 4.71
prevention of the movement of patients between groups after allocation, and 
the use of intention-to-treat analysis
W = 4.74, P = 0.03 0.03 y = 0.054x - 13.25
the blinding of the patients to the treatment they received W = 0.04, P = 0.84 0.000 y = 0.006x + 0.77
the blinding of the health care providers to the treatments received by the 
patients
W = 0.16, P = 0.69 0.001 y = -0.010x + 0.32
the blinding of the outcome observer to the treatment received by the patient W = 0.27, P = 0.60 0.002 y = 0.012x - 0.57
adequacy of follow-up W = 3.25, P = 0.07 0.02 y = 0.043x - 3.25
allocation concealment W = 0.23, P = 0.88 0.000 Y = 0.004x - 7.64BMC Medical Research Methodology 2005, 5:7 http://www.biomedcentral.com/1471-2288/5/7
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medical science and that it should not be discounted
solely because of its country-of-origin or the language in
which it was written. As another difference, the CIG trials
registry involved hand-searches of journals and lists of ref-
erences provided by authorities in the field of brain injury,
which are not features of the PubMed MEDLINE search
and which may predispose the CIG trials registry search
technique toward recovering more recently-published
manuscripts. Recently published manuscripts may be of
higher quality, thereby biasing the longitudinal measure-
ment of quality in the RCT manuscript sample provided
by the CIG trials registry. Alternatively, such extra efforts
would be considered by most to improve on the yield of a
search technique by including journals and books that are
not indexed by computerized databases.
Arguments can be made that either of the search tech-
niques provided a more representative sample of RCT
manuscripts from the field of brain injury, but which
search technique is superior – if either can be said to be so
– is not a concern of the current study. It was solely our
intention to compare the findings provided by two com-
monly-used search techniques to demonstrate that the
search technique can in fact influence the measurement of
the change in RCT quality over time. We acknowledge a
priori that neither of the search techniques we used neces-
sarily sampled RCTs from the field of brain injury in a rep-
resentative manner. Furthermore, we do not claim to have
accurately measured how the quality of RCT manuscripts
is changing over time in the field of brain injury with
either one of them. This is because we are not confident
that either search technique provided a representative
sampling of the field of brain injury (i.e., that either search
technique had access to all the relevant manuscripts).
With regards to the field of brain injury, it is clear from our
observations that neither the PubMed MEDLINE search
nor the CIG Trials Registry can claim to be complete, as
each search technique failed to identify a large number of
RCT manuscripts that were found by the other search
technique. In other fields of medical science there may be
specialized databases or registries that claim to identify all
relevant manuscripts (e.g., the Renal Registry in the field
of nephrology [F.P. Schena, personal communication]).
The authors of the current communication cannot under-
stand how such a claim can be made or proven, since
demonstrating the completeness of a search strategy
would require proving that there are no relevant manu-
scripts that it does not identify. Ultimately, proving that
something does not exist is scientifically impossible.
Alternatively, it might be claimed that a search strategy
identifies  the majority of relevant manuscripts. This, of
course, depends upon (1) the definition of a majority and
(2) the assumption that the finding of even a few relevant
manuscripts not identified by the search strategy means
there are no other such manuscripts outside of the reach
of that search strategy. Again, such a claim would depend
upon the assumption that the inability to find further
relevant manuscripts indicates that no further relevant
manuscripts exist; as described above, this is a scientific
impossibility. Rather than claiming perfection or near-
perfection, it would seem to us to be more appropriate
and accurate to claim that a given search strategy has
exhausted all options for identifying relevant
manuscripts.
What, then, should be done to avoid a biasing influence
related to the search technique during reviews of RCT
quality over time? The simplest means of avoiding a such
an influence would have apparently been to use multiple
search techniques in order to better sample the parent
population of RCT manuscripts in a field of medical sci-
ence. In general, including multiple techniques into a sin-
gle 'comprehensive' search would be preferable to a
simple search involving only a single technique, but even
so this does not ensure that the combination is truly com-
prehensive (as we have demonstrated with the CIG Trials
Registry). Essentially this was the goal of the CIG trials reg-
istry, but even it did not completely encompass the sam-
ple of manuscripts identified by the PubMed MEDLINE
search despite involving a MEDLINE search of its own.
Similarly, previous reviews of RCT quality have often
involved secondary searches following an initial compu-
terized search, but such efforts certainly cannot match the
breadth and thoroughness of that from the Cochrane Col-
laboration. If such reviews of RCT quality are to judge
entire fields of medical science it would seem that the
search techniques they employ must be shown to produce
a representative sampling of the parent population of RCT
manuscripts as well as a high yield from that parent pop-
ulation. We hope that the findings presented here bring
more attention to this concern in future reviews of the
change in RCT quality over time.
Conclusions
We demonstrated that measuring the change in quality
over time of a sample of RCT manuscripts from the field
of brain injury can be greatly affected by the search tech-
nique. This poorly recognized factor may make measure-
ments of the change in RCT quality over time within a
given field of medical science unreliable. The search strat-
egy should be accurately reported in any study that
attempts to follow trends in the quality of RCT manu-
scripts over time, and its limitation in sampling the RCT
manuscripts from a field of medical science should be
acknowledged and evaluated.
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